Literature DB >> 28375418

Unexpected Serious Cardiac Arrhythmias in the Setting of Loperamide Abuse.

Somwail Rasla1, Parag Parikh, Amy St Amand2, Marina K Garas3, Amr El Meligy1, Taro Minami4, Nishant R Shah.   

Abstract

Loperamide (Imodium) is a non-prescription opioid receptor agonist available over-the-counter for the treatment of diarrhea. When ingested in excessive doses, loperamide can penetrate the blood-brain barrier and is reported to produce euphoria, central nervous system and respiratory depression, and cardiotoxicity. There is an emerging trend in its use among drug abusers for its euphoric effects or for self-treatment of opioid withdrawal. We report a case of ventricular dysrhythmias associated with loperamide abuse in a 28-year-old man who substituted loperamide for the opioids that he used to abuse. [Full article available at http://rimed.org/rimedicaljournal-2017-04.asp].

Entities:  

Keywords:  Arrhythmias; Lopermide; QTc prolongation; Ventricular tachycardia; opioid abuse

Mesh:

Substances:

Year:  2017        PMID: 28375418

Source DB:  PubMed          Journal:  R I Med J (2013)        ISSN: 0363-7913


  4 in total

Review 1.  Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity.

Authors:  Michael S Toce; Peter R Chai; Michele M Burns; Edward W Boyer
Journal:  J Med Toxicol       Date:  2018-10-30

2.  Loperamide-induced ventricular tachycardia storm.

Authors:  Mohamed Daoub; Philippa Cawley; Jonathan Sahu
Journal:  Br J Cardiol       Date:  2021-10-13

Review 3.  Opioids and Cardiac Arrhythmia: A Literature Review.

Authors:  Mina Behzadi; Siyavash Joukar; Ahmad Beik
Journal:  Med Princ Pract       Date:  2018-08-02       Impact factor: 1.927

4.  Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports.

Authors:  Fabrizio Schifano; Stefania Chiappini
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.